Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2010-03-26 Annual Report
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
2009年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2009 Annual Report Summary" of 马应龙药业集团股份有限公司, indicating it is a summary of the full annual report. It contains detailed financial data for the year 2009, including revenue, profit, assets, shareholder information, management discussion and analysis, and capital usage. It also includes audit information with a standard unqualified opinion from the accounting firm. The length is substantial (15,000 characters), and the content includes comprehensive financial and operational data for the full fiscal year 2009. This matches the definition of an Annual Report (10-K) which covers company activity and full financial performance for the year. Therefore, the document should be classified as an Annual Report (10-K). FY 2009
2010-03-26 Chinese
2009年年度报告
Annual Report Classification · 100% confidence The document is titled '2009 年年度报告' which translates to '2009 Annual Report' for Mayinglong Pharmaceutical Group Co., Ltd. It contains detailed sections typical of an annual report such as company basic information, accounting data and business data summary, changes in share capital and shareholders, board of directors and senior management information, corporate governance structure, shareholder meeting summaries, board reports, supervisory board reports, important matters, and financial accounting reports. The document length is substantial (15,000 characters) and includes comprehensive financial data and management discussion. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2009
2010-03-26 Chinese
关于2009年度业绩预增的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (496 characters) about the company's expected performance increase for the fiscal year 2009. It provides preliminary profit estimates and states that the detailed data will be disclosed in the 2009 Annual Report. The document explicitly mentions that the performance forecast has not been audited and is a forecast, not a full financial report. It is an announcement of expected earnings, not the actual earnings release or annual report itself. Therefore, it fits best as a Regulatory Filing (RNS) because it is a regulatory announcement about performance expectations without substantive financial statements or detailed analysis.
2010-01-08 Chinese
第六届董事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement from the board of directors of 马应龙药业集团股份有限公司 regarding the appointment of a new company secretary due to a personnel change. It details the board meeting resolution and includes a brief personal resume of the newly appointed secretary. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to shareholder votes or dividends. The content clearly relates to a change in senior management or board-related personnel. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused on management change, confirming this classification with high confidence.
2010-01-08 Chinese
股改限售流通股上市公告
Regulatory Filings Classification · 95% confidence The document is titled as a "股改限售流通股上市公告" which translates to "Announcement of Listing of Restricted Circulating Shares after Share Reform". It details the number of shares being listed, dates, shareholder commitments, shareholding changes, and confirmations from sponsoring institutions. The document is an official announcement regarding the listing of restricted shares following a share reform process. It does not contain financial statements, earnings data, or management discussion, but rather focuses on share listing details and compliance with share reform commitments. The document length is over 10,000 characters, indicating it is not a brief notice but a detailed announcement. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about share listing and shareholder information that does not fit into other specific categories like capital changes or earnings releases. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2009-12-01 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the reduction in shareholding by two entities (武汉国有资产经营公司 and 武汉华汉投资管理有限公司) in 马应龙药业集团股份有限公司, including specific share quantities, percentages, transaction dates, and legal references to securities laws and disclosure regulations. The document is a formal disclosure of changes in significant share ownership, including the nature of the share transactions and compliance with relevant laws. It does not contain financial statements, earnings data, or management commentary, nor is it an announcement of a report publication. The content fits the definition of a Major Shareholding Notification, which involves notifying changes in significant share ownership levels crossing thresholds. Therefore, the appropriate classification is MRQ (Major Shareholding Notification). The document length (5306 characters) supports it being a full report rather than a brief announcement or certification.
2009-11-06 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.